Crossref
Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer
ONCOLOGY · 2022
DOI: 10.46883/2022.25920941 ↗Kurz gefasst
Fachartikel in der Zeitschrift ONCOLOGY, 2022. Verfasst von Jun Gong. Beteiligte Einrichtung: Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai, Los Angeles, CA.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AgedAntineoplastic AgentsCisplatinCystectomyDisease-Free SurvivalFemaleHumansMaleMuscle NeoplasmsNeoadjuvant TherapyNeoplasm InvasivenessRetrospective StudiesTime FactorsUrinary BladderUrinary Bladder Neoplasms
Substanzen
Antineoplastic AgentsCisplatin
Autor:innen und Institutionen
- Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai, Los Angeles, CA.
Zitieren
APA
Gong, J. (2022). Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer. ONCOLOGY. https://doi.org/10.46883/2022.25920941
Vancouver
Gong J. Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer. ONCOLOGY. 2022. doi:10.46883/2022.25920941
BibTeX
@article{Gong2022,
author = {Gong, Jun},
title = {Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer},
journal = {ONCOLOGY},
year = {2022},
doi = {10.46883/2022.25920941}
}
EUVIMED